510(k) K121092

FLOWEASE [SUBCUTANEOUS] INFUSION SET by Baxter Healthcare Corp — Product Code FPA

K121092 is an FDA 510(k) premarket notification submitted by Baxter Healthcare Corp for the device "FLOWEASE [SUBCUTANEOUS] INFUSION SET". The FDA issued a decision of Substantially Equivalent on June 29, 2012. The device falls under product code FPA (Set, Administration, Intravascular), a Class II device regulated under 21 CFR 880.5440. Baxter Healthcare Corp has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
June 29, 2012
Date Received
April 10, 2012
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Set, Administration, Intravascular
Device Class
Class II
Regulation Number
880.5440
Review Panel
HO
Submission Type